Home/CraniUS Therapeutics/Michael Maglin

MM

Michael Maglin

CEO

CraniUS Therapeutics

Therapeutic Areas

Oncology Neurology Neurodegenerative Diseases

CraniUS Therapeutics Pipeline

Drug	Indication	Phase
NeuroPASS Device Platform	Aggressive Brain Tumors, Alzheimer's Disease, Parkinson's Disease	Pre-clinical

Leadership Team at CraniUS Therapeutics

Dr. Chad Gordon

Founder / Pioneer (assumed)

View full CraniUS Therapeutics profile